Oral Session 1-9C AML: Genetic abnormalities

[OS1-9C-5] WT1 expression at onset of AML correlated collaborative cytogenetic abnormality and WT1 SNP status

Masahiro Onozawa¹, Daisuke Hidaka¹, Junichi Hashiguchi¹, Naohiro Miyashita¹, Shinichi Fujisawa², Eiko Hayase^1,2, Satoshi Yamamoto³, Yutaka Tsutsumi⁴, Yoshihito Haseyama⁵, Takahiro Nagashima⁶, Akio Mori⁷, Shuichi Ota⁸, Hajime Sakai⁹, Toshimichi Ishihara¹⁰, Takuto Miyagishima¹¹, Yasutaka Kakinoki¹², Mitsutoshi Kurosawa¹³, Hajime Kobayashi¹⁴, Hiroshi Iwasaki¹⁵, Takeshi Kondo⁷, Takanori Teshima^1,2 (1.Department of Hematology, Hokkaido Univ., Sapporo, Japan, 2.Hokkaido Univ. Hospital, Laboratory and Transfusion Medicine, Sapporo, Japan, 3.Department of Hematology, Sapporo City General Hospital, Sapporo, Japan, 4.Hakodate Municipal Hospital, Hakodate, Japan, 5.Tonan Hospital, Sapporo, Japan, 6.Japanese Red Cross Kitami Hospital, Kitami, Japan, 7.Aiiku Hospital, Sapporo, Japan, 8.Sapporo Hokuyu Hospital, Sapporo, Japan, 9.Teine Keijinkai Hospital, Sapporo, Japan, 10.Kin-ikyo Chuo Hospital, Sapporo, Japan, 11.Kushiro Rosai Hospital, Kushiro, Japan, 12.Asahikawa City Hospital, Asahikawa, Japan, 13.Hokkaido Cancer Center, Sapporo, Japan, 14.Obihiro Kosei General Hospital, Obihiro, Japan, 15.Sapporo Kosei General Hospital, Sapporo, Japan)